multiple dose study [Design Issues]

posted by Mahesh M – India, 2016-05-30 11:42 (3179 d 17:56 ago) – Posting: # 16370
Views: 6,128

EMA Published PAR regarding Metformin prolonged release tablet

14 May 2016 | Yaltormin SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets (metformin hydrochloride) - PL 29831/0655-0657; UK/H/5957/001-3/DC (1640Kb)

As per this PAR Applicant performed 5 BE study
1) 1000 mg Fasting
2) 1000 mg fed
3) 1000 mg fasting multiple dose study
4) 750 mg
5) 500 mg fed

As per SPC “No accumulation is observed after repeated administration of up to 2000mg of metformin as prolonged release tablets then why applicant performed multiple dose study?

As per PIL “You should take Glucophage SR with or immediately after food.” But applicant performed multiple dose study under fasting condition not under fed condition?

Kindly share your thoughts on that?

Regards
M


Edit: PAR linked. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,662 registered users;
34 visitors (0 registered, 34 guests [including 10 identified bots]).
Forum time: 04:38 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5